DASA Hospital Brasilia

Brasília 71681-603

1 studies enrolling now · 2 studies all time

What they study most

Metastatic HER2-positive Breast Cancer, Non-small Cell Lung Cancer Metastatic

Studies at this site

• A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer — Recruiting now
• Predictive Multimodal Signatures Associated With Response to Treatment and Prognosis of Patients With Stage IV Non-small Cell Lung Cancer — Running, not enrolling